Prevalence of impaired glucose metabolism in β-thalassemic children receiving hypertransfusions with a suboptimal dosage of iron-chelating therapy
- 25 September 2007
- journal article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 167 (8) , 873-876
Abstract
A cross-sectional study of impaired glucose metabolism was carried out in 48 β-thalassemic patients receiving hypertransfusions. An oral glucose tolerance test (OGTT) was performed using the method and criteria of the American Diabetes Association (ADA). Diabetes mellitus was diagnosed in two patients, and impaired glucose tolerance was found in four patients, giving a prevalence of impaired glucose metabolism of 12.5% in our patient population. The significant clinical characteristics associated with the diagnosis of impaired glucose metabolism were wasting (−2.15/−0.86 SDS, p = 0.025), stunting (−2.69/−1.22 SDS, p = 0.03), higher ferritin levels (8679/4710 μg/L, p = 0.005), splenectomy (50/9.5%, p = 0.012), and lower area under curve (AUC) of insulin secretion after OGTT (40.0/77.7, p = 0.002). The significant decrease of AUC insulin in thalassemic patients with an impaired glucose tolerance test suggests that the pathogenesis may originate from pancreatic β-cell damage rather than from insulin resistance. In conclusion, the prevalence of impaired glucose tolerance in our population of thalassemic patients receiving hypertransfusions with suboptimal iron chelating therapy was 12.5%. The clinical characteristics of thalassemic patients who developed impaired glucose tolerance were wasting, stunting, higher ferritin levels, splenectomy, and lower AUC insulin.Keywords
This publication has 26 references indexed in Scilit:
- Survival and Complications in ThalassemiaAnnals of the New York Academy of Sciences, 2005
- Endocrine Gland Abnormalities in Thalassemia Major: Λ Brief ReviewJournal of Pediatric Endocrinology and Metabolism, 2003
- Abnormal Glucose Tolerance in Transfusion-Dependent β-Thalassemic PatientsDiabetes Care, 2001
- Thyroid disorders and diabetes mellitus as complications of thalassaemia majorActa Paediatrica, 1994
- Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia MajorNew England Journal of Medicine, 1994
- Insulin Resistance and Hyperinsulinemia in Patients with Thalassemia Major Treated by HypertransfusionNew England Journal of Medicine, 1988
- Hyperinsulinemia in a Population at High Risk for Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1986
- Early iron overload in beta-thalassaemia major: when to start chelation therapy?Archives of Disease in Childhood, 1982
- Hormonal changes in thalassaemia major.Archives of Disease in Childhood, 1976
- Endocrinopathy in thalassaemia major.Archives of Disease in Childhood, 1976